The science is rather elegant: protein stimulates the release of incretin hormones, including our star player GLP-1, which then works its magic on blood sugar regulation
Patients with pre-existing bowel disorders or diabetic gastroparesis, those taking concurrent medications that slow gut motility (such as opioids, tricyclic antidepressants, calcium channel blockers, iron supplements, or antipsychotics), and older adults may be at increased risk
3) Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) The FDA granted approval to Genvoya in 2015 as a comprehensive treatment for HIV-1 infection
It also stops reactions at the injection site
In light of these studies, we want to remind patients and healthcare providers that while GLP-1 drugs can be effective for weight loss, they may come with unintended consequences," said Elaine Shi, Co-CEO at BodySpec